ArticleJournal of rheumatic diseases2025

Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs.

Bo Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.